Five species of edible mushrooms, Lentinula edodes, Pleurotus ostreatus, Pholiota nameko, Macrolepiota bonaerensis and Agaricus blazei, were tested for their potential to inhibit the in vitro growth of the pathogenic yeast Candida albicans. Only L. edodes had a fungistatic effect on this human pathogen. The inhibitory compound was produced intra and extracellularly in submersed L. edodes culture, and was also present in fresh and dehydrated mushroom basidiocarps. The fungistatic compound was heat sensitive and lost activity after 72 hours.
Agaricus blazei Murill on C. albicans. Mycelia from each species was obtained by tissue culture from basidiocarps and kept in PDA medium (Potato Dextrose Agar). Discs of mycelia were transferred to potato broth and after 30 days growth at 25ºC the mycelial growth substrate was obtained. An aliquot of 0.5 ml of this substrate was added to tubes containing 5 ml of potato broth added to a suspension of 10 8 cells ml -1 of C. albicans (strain 577) (the cells were obtained by culture in potato broth for 24 hours at 25ºC and washed three times in PBS by centrifuge). At 0, 24, 48 and 72 hours at 25ºC the number of C. albicans cells was estimated in a Newbauer chamber and compared with the control (yeast grown in the medium without the mycelial growth substrate). Under these conditions, only the L. edodes mycelium, popularly known as shiitake, showed inhibitory action on C. albicans multiplication. The minimum dose of the mycelial growth substrate capable of inhibiting the multiplication of the C. albicans cells after 24, 48 and 72 hours of exposure was 4%, 6% and 10%, respectively ( Table 1 ). The inhibitory agent is probably volatile or can be degraded or metabolized Candida albicans is a yeast present in the human gastrointestinal and genital-urinary tracts, and is very frequent among the infections caused by fungi in immunedepressed individuals, diabetics, and HIV carriers. In cases of endocrinopathies such as hypothireoidism, hypoadrenalism, and diabets, there is an increase in the predisposition to candidiasis attributed to the increase in glycemia and immune deficiency, which often hinders treatment (6). The incidence of candidas also increases during pregnancy due to an increase in the concentration of glycogen by cells in the vaginal mucous tissues, causing disconfort to the patient (7) . Extensive clinical studies, primarily in Japan, have clearly demonstrated that a number of mushroom species have medicinal and therapeutic value, in the prevention and treatment of tumors, viral and bacterial diseases, hypercholesterolemia and blood platelet aggregation (1, 2, 4) .
In this preliminary report we tested the antagonic potential of edible mushroom species Lentinula edodes, Pleurotus ostreatus, Pholiota nameko, Macrolepiota bonaerensis, and during the yeast growth period. When daily doses of L. edodes growth substrate (0.5 ml every 24 hours) were added to the C. albicans culture, the number of cells remained constant and lower than 10 4 units ml -1 of suspension, even after 72 hours incubation, showing the fungistatic effect of L. edodes on C. albicans. This fact prompted us to examine whether this antibiotic effect is kept in the mushroom in the form as it is consumed by man, fresh or dehydrated. Emerged basidiocarps from eucalyptus (Eucaliptus saligna) logs were used fresh and dehydrated. For dehydration, fresh mushrooms were placed in a dehydration chamber to 60ºC until complete water loss. The dehydrated mushroom was ground to a fine powder and placed in infusion at the proportion of 6g: 10ml distilled water. The fresh mushrooms were macerated in distilled water (60g/150 ml). Part of this maceration was heated to 100ºC for 10 minutes and the other part used fresh. The preparations were filtered in Watmann filter paper and in Millipore 0.45 mm and 0.22 µm and applied to the C. albicans culture at different doses (0, 10, 15, 20 and 30%). The number of yeast cells was estimated in a Newbauer chamber after 0, 8, 12, 24 and 48h. After 24 hours, it was possible to observe the fresh L. edodes basidiocarp inhibitory effect, but after 48 hours of exposure to the inhibitory agent the cells returned to growth, confirming the fungistatic effect shown in Fig. 1 . The same was observed when the powder of dehydrated mushroom was tested (Fig. 2) .
Heat-treatment of the filtrate inactivated the inhibitory agent. Ishikawa (3) studied the inhibitory activity of L. edodes on Bacillus, Listeria, Staphylococcus, Acinetobacter, Citrobacter, Enterobacter, Escherichia, Klebsiella, Proteus, Pseudomonas, Salmonella, Serratia, Shigella and Yersinia, observing that the greatest activity was on Gram positive bacteria, as also observed by Komemushi et al. (5) . However, this antimicrobial compound was shown to be heat stable, unlike the compound described in this study. In conclusion, the findings of this study have shown that L. edodes produces a fungistatic agent, which is able to control C. albicans multiplication. The agent is present both in the basidiocarps and in the mycelia, which is secreted in the growth medium. This substance is heat sensitive and looses activity after 72 hours.
